Biovie Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Biovie Stock Summary

Biovie competes with Inozyme Pharma, Day One, Terns Pharmaceuticals, Eledon Pharmaceuticals, and Hookipa Pharma. BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Biovie Key Financial Ratios

Biovie Key Balance Sheet Accounts

Biovie Key Income Statement Accounts

Biovie Key Cash Accounts

Biovie Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biovie's current stock value. Our valuation model uses many indicators to compare Biovie value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biovie competition to find correlations between indicators driving Biovie's intrinsic value. More Info.Biovie Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . As of now, Biovie's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biovie's earnings, one of the primary drivers of an investment's value.

Biovie Inc Systematic Risk

Today, most investors in Biovie Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biovie's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biovie growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Biovie help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biovie Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biovie Inc based on widely used predictive technical indicators. In general, we focus on analyzing Biovie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biovie's daily price indicators and compare them against related drivers.

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.